Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)
Public ClinicalTrials.gov record NCT00110851. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Effects of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to evaluate the safety and efficacy of PN2034 administered to type 2 diabetics on concomitant rosiglitazone and metformin (or Avandamet) therapy as measured by change in glycosylated hemoglobin (HbA1c) levels from baseline to Week 12. Also the study will evaluate the effect of PN2034 on glucose control as measured by fasting plasma glucose (FPG) and on fasting lipid levels: triglycerides, total cholesterol, high-density lipoproteins (HDL), low-density lipoproteins (LDL), and very low-density lipoproteins (VLDL).
Study identification
- NCT ID
- NCT00110851
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 90 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 72 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Aug 2007 (Actual)
- Last update posted
- Aug 23, 2007
2005 – 2007
United States locations
- U.S. sites
- 20
- U.S. states
- 9
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Phoenix Internal Medicine Associates | Waterbury | Connecticut | 06708 | — |
| University Clinical Research-DeLand | DeLand | Florida | 32720 | — |
| Center for Diabetes and Endocrine Care | Hollywood | Florida | 33021 | — |
| Genesis Research International | Longwood | Florida | 32779 | — |
| Baptist Diabetes Associates | Miami | Florida | 33156 | — |
| Andres Patron, DO PA | Pembroke Pines | Florida | 33028 | — |
| CLIRECO, Inc. | Tamarac | Florida | 33321 | — |
| Endocrine Clinical Research | Winter Park | Florida | 32789, | — |
| PRN of Kansas | Wichita | Kansas | 67203 | — |
| Medical Research Associates of Charlotte | Charlotte | North Carolina | 28211 | — |
| Neem Research Group of Charlotte | Charlotte | North Carolina | 28262 | — |
| Unifour Medical Research Associates | Hickory | North Carolina | 28601 | — |
| Neem Research Group of Raleigh | Raleigh | North Carolina | 27609 | — |
| Piedmont Medical Research Associates | Winston-Salem | North Carolina | 27103 | — |
| COR Clinical Research, LLC | Oklahoma City | Oklahoma | 73103 | — |
| Clinical Research Institute of Southern Oregon, PC | Medford | Oregon | 97504 | — |
| Camp Hill Clinical Research Center | Camp Hill | Pennsylvania | 17011 | — |
| Neem Research Group | Columbia | South Carolina | 29201 | — |
| Palmetto Medical Research Associates | Mt. Pleasant | South Carolina | 29464 | — |
| Oaks Medical Center | Spring | Texas | 77386 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00110851, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 23, 2007 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00110851 live on ClinicalTrials.gov.